Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Dev Orig Health Dis ; 12(1): 124-131, 2021 02.
Artículo en Inglés | MEDLINE | ID: mdl-32241331

RESUMEN

Prenatal exposure to mercury in utero causes abnormal foetal growth and adverse outcomes. DNA methylation is currently considered a possible mechanism through which this occurs. However, few studies have investigated the association between prenatal exposure to mercury and DNA methylation in detail. This study aimed to clarify the relationship between prenatal exposure to total mercury (Hg) and DNA methylation and its associations with sex-specific characteristics in male and female offspring. In a birth cohort study known as the Chiba study of Mother and Child Health, the DNA methylation status in cord tissue and Hg concentrations in cord serum were examined. A total of 67 participants (27 males and 40 females) were analysed based on Spearman's correlations, adjusted by a false discovery rate of the sex of each offspring. Only one methylated locus was positively correlated with Hg concentrations in cord serum in male offspring, but not in female offspring, and was annotated to the haloacid dehalogenase-like hydrolase domain-containing protein 1 (HDHD1) gene on chromosome X. This locus was located in the intron of the HDHD1 gene body and is a binding site for the zinc finger protein CCCTC-binding factor. One of the other loci, located in HDHD1, was highly methylated in the group with higher mercury concentrations, and this locus was in the gene body of HDHD1. Our results suggest that prenatal exposure to Hg might affect the epigenetic status of male foetuses.


Asunto(s)
Metilación de ADN/efectos de los fármacos , Epigénesis Genética/efectos de los fármacos , Exposición Materna/efectos adversos , Mercurio/efectos adversos , Efectos Tardíos de la Exposición Prenatal/genética , Adulto , Cromosomas Humanos X/efectos de los fármacos , Cromosomas Humanos X/genética , Exposición a Riesgos Ambientales/efectos adversos , Exposición a Riesgos Ambientales/prevención & control , Contaminantes Ambientales/efectos adversos , Contaminantes Ambientales/sangre , Femenino , Sangre Fetal/química , Feto/irrigación sanguínea , Feto/efectos de los fármacos , Sitios Genéticos/efectos de los fármacos , Humanos , Masculino , Edad Materna , Exposición Materna/prevención & control , Mercurio/sangre , Nucleotidasas/efectos de los fármacos , Nucleotidasas/genética , Embarazo , Efectos Tardíos de la Exposición Prenatal/inducido químicamente , Efectos Tardíos de la Exposición Prenatal/prevención & control , Factores Sexuales , Cordón Umbilical/efectos de los fármacos
2.
Artículo en Inglés | MEDLINE | ID: mdl-31382687

RESUMEN

Maternal exposure to polychlorinated biphenyls (PCBs) results in abnormal fetal development, possibly because of epigenetic alterations. However, the association between PCB levels in cord serum with fetal DNA methylation status in cord tissue is unclear. This study aims to identify alterations in DNA methylation in cord tissue potentially associated with PCB levels in cord serum from a birth cohort in Chiba, Japan (male neonates = 32, female neonates = 43). Methylation array analysis identified five sites for female neonates (cg09878117, cg06154002, cg06289566, cg12838902, cg01083397) and one site for male neonates (cg13368805) that demonstrated a change in the methylation degree. This result was validated by pyrosequencing analysis, showing that cg06154002 (tudor domain containing 9: TDRD9) in cord tissue from female neonates is significantly correlated with total PCB levels in cord serum. These results indicate that exposure to PCBs may alter TDRD9 methylation levels, although this hypothesis requires further validation using data obtained from female neonates. However, since the present cohort is small, further studies with larger cohorts are required to obtain more data on the effects of PCB exposure and to identify corresponding biomarkers.


Asunto(s)
Metilación de ADN/efectos de los fármacos , Sangre Fetal/metabolismo , Exposición Materna , Bifenilos Policlorados/sangre , Cordón Umbilical/metabolismo , Biomarcadores , Estudios de Cohortes , ADN Helicasas/efectos de los fármacos , Femenino , Desarrollo Fetal/efectos de los fármacos , Humanos , Recién Nacido , Japón , Masculino
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA